শুক্রবার | ১৪ই আগস্ট, ২০২০ ইং |

‘Coronavirus vaccine likely by September’

News Desk | dhaka24.net:
Vaccine major Serum Institute of India on Wednesday said it plans to start production of the COVID-19 vaccine developed by Oxford University in the next two to three weeks and hopes to bring it to the market by October if the human clinical trials are successful, reports PTI.

The Pune-based company has partnered with Oxford University as one of the seven global institutions manufacturing the vaccine.

“Our team has been working closely with Dr Hill from Oxford University, and we are expecting to initiate production of the vaccine in 2-3 weeks and produce 5 million doses per month for the first 6 months, following which, we hope to scale up production to 10 million doses per month,” Serum Institute India (SII) CEO Adar Poonawalla said.

SII has collaborated with scientists at Oxford University for a malaria vaccine project in the past and can say with certainty that they are some of the best scientists, he added.

“We expect the (COVID-19) vaccine to be out in the market by September – October, only if the trials are successful with the requisite safety and assured efficacy. We will be starting trials in India for this vaccine hopefully over the next 2-3 weeks’ time,” Poonawalla said.

SII will be manufacturing the vaccine in anticipation of clinical trials succeeding by September-October in the UK, he added.

The company plans to initiate the trials in India for the vaccine with necessary regulatory approvals, which are underway presently.

fb-share-icon35
fb-share-icon20

Enjoy this blog? Please spread the word :)